Renal Failure
Volume 43, 2021 - Issue 1
Open access
2,438
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study
Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial
Zhaohui Nia Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaCorrespondence[email protected]
, Zhen Zhanga Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
, Zanzhe Yua Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
, Fuming Lub Department of Nephrology, Huashan Hospital, Fudan University, Shanghai, China
, Changlin Meic Department of Nephrology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China
, Xiaoqiang Dingd Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China
, Weijie Yuane Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China
, Wei Zhangf Department of Nephrology, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
, Gengru Jiangg Department of Nephrology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
, Min Sunh Department of Nephrology, Huadong Hospital, Fudan University, Shanghai, China
, Liqun Hei Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
, Yueyi Dengj Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
, Huihua Panga Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
& Jiaqi Qiana Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
show all
Pages 1214-1221
|
Received 18 Jan 2021, Accepted 27 Jul 2021, Published online: 15 Aug 2021
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.